First author | Year | Control source | Cancer types | Genotyping method | Case/control | HWE | Case | Control | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
*1/1 | *1/2 | *2/2 | *1/1 | *1/2 | *2/2 | |||||||
Sun | 2008 | PB | Liver cancer | PCR | 190/175 | 0.587 | 72 | 110 | 8 | 99 | 67 | 9 |
Qi | 2010 | HB | Liver cancer | PCR | 86/78 | 0.799 | 27 | 51 | 8 | 36 | 34 | 7 |
Zhai | 2012 | PB | Hepatocellular carcinoma | PCR | 102/135 | 37 | 52 | 13 | ||||
Wang | 2011 | HB | Primary liver cancer | PCR | 303/515 | 0.941 | 107 | 156 | 40 | 272 | 205 | 38 |
Deng | 2005 | HB | Lung cancer | PCR | 162/134 | 0.285 | 54 | 91 | 21 | 67 | 59 | 8 |
Li | 2006 | PB | Lung cancer | PCR | 131/104 | 0.155 | 70 | 56 | 5 | 57 | 36 | 11 |
Li | 2012 | HB | Breast cancer | PCR | 208/211 | 0.185 | 90 | 100 | 18 | 129 | 76 | 6 |
Fan | 2012 | HB | Breast cancer | PCR | 732/649 | 0.356 | 326 | 342 | 64 | 346 | 262 | 41 |
Yang | 2012 | PB | Gallbladder carcinoma | PCR | 91/155 | 0.851 | 34 | 45 | 12 | 88 | 57 | 10 |
Wang | 2013 | HB | Nasopharyngeal carcinoma | PCR | 134/327 | 0.07 | 74 | 48 | 12 | 163 | 145 | 19 |
Wang | 2010 | HB | Pancreatic cancer | PCR | 58/156 | 0.977 | 24 | 26 | 8 | 74 | 67 | 15 |
Xu | 2012 | HB | Ovarian cancer | PCR | 282/365 | 0.64 | 122 | 115 | 45 | 231 | 108 | 26 |
Meng | 2011 | HB | Cervical carcinoma | PCR | 317/416 | 0.835 | 127 | 153 | 37 | 225 | 163 | 28 |
Meng | 2013 | HB | Endometrial carcinoma | PCR-RFLP | 283/378 | 0.072 | 93 | 135 | 55 | 200 | 140 | 38 |
Liu | 2007 | HB | Gastric cancer | PCR | 214/350 | 0.484 | 88 | 107 | 19 | 199 | 133 | 18 |
Cheng | 2008 | HB | Colon/rectal/esophageal cancer | PCR | 701/350 | 0.484 | 362 | 293 | 46 | 199 | 133 | 18 |
Sun | 2007 | HB | Lymphoma | PCR | 166/350 | 0.484 | 72 | 71 | 23 | 199 | 133 | 18 |